Trial of Surufatinib Combined With Toripalimab in the Treatment of Peritoneal Metastatic Carcinoma of Gastrointestinal or Primary Peritoneal Cancer
Clinical trial NCT05030246 · UNKNOWN
Trial details
- NCT number
- NCT05030246
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-14
- Primary completion
- 2023-04-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.